The four FoB’s in the AMGN-ACT collaboration are Herceptin, Avastin, Rituxan, and Erbitux—scan about 1/3 of the way down in http://phx.corporate-ir.net/phoenix.zhtml?c=65778&p=irol-newsArticle&ID=1777988 .